Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The NGS Oncology Market?

The expansion of the ngs oncology market has been swift in the past few years. The market is projected to escalate from $17.36 billion in 2024 to $19.33 billion in 2025, with a compound annual growth rate (CAGR) of 11.3%. This exceptional growth during the historical period can be linked to an increase in cancer diagnosis, advanced research in cancer genomics, heightened public awareness, development of healthcare facilities, and a surge in the demand for personalized treatment.

The market size of ngs oncology is anticipated to experience swift expansion in the upcoming years, reaching $29.64 billion in 2029 with a CAGR of 11.3%. This growth during the projection period is credited to the expansion of companion diagnostics, increasing incidences of cancer, enhanced government and healthcare investments, widening clinical applications, and the growing trend of targeted therapies. Significant trends in the forecast period consist of the incorporation of AI and machine learning, progress in single-cell sequencing, improved sequencing platforms, developments in liquid biopsy technology, and upgrades in high-throughput sequencing platforms.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24337&type=smp

Which Growth Drivers Are Shaping The NGS Oncology Market Outlook?

The surge in cancer incidences is anticipated to fuel the expansion of the NGS oncology market in the future. Cancer, characterized by the uncontrolled and potentially widespread growth of anomalous cells, interferes with regular bodily functions. The surge in cancer cases is predominantly due to the aging populace, as the chance of cancer occurrence escalates with age. NGS oncology contributes to mitigating the rising cancer incidences by facilitating early detection, precise diagnosis, and customized treatment through comprehensive genetic profiling of tumors. For example, the American Cancer Society, a non-profit organization based in the U.S., stated that in 2022, approximately 20 million fresh cancer cases were recorded worldwide, leading to 9.7 million fatalities. Primarily propelled by population growth, the global cancer burden is predicted to increase to 35 million cases by 2050. Consequently, the escalating prevalence of cancer will stimulate the growth of the NGS oncology market.

What Are The Primary Segmentation Parameters In The NGS Oncology Market?

The ngs oncologymarket covered in this report is segmented –

1) By Sequencing Technology: Targeted Sequencing; Genomics; Transcriptomics; Epigenomics

2) By Offering: Platform; Kits; Services

3) By Workflow: Pre-Sequencing; Sequencing; Data Analysis

4) By Application: Genetic Screening; Hereditary Genetic Testing; Hematological Malignancies; Solid Tumors; Other Applications

5) By End User: Hospitals And Clinics; Clinical Research Organizations (CROs); Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:

1) By Targeted Sequencing: Whole Exome Sequencing (WES); Amplicon-Based Sequencing; Hybridization-Based Sequencing

2) By Genomics: Whole Genome Sequencing (WGS); Structural Variant Detection; Copy Number Variation (CNV) Analysis

3) By Transcriptomics: RNA Sequencing; Single-Cell Transcriptomics; Non-coding RNA Analysis

4) By Epigenomics: DNA Methylation Sequencing; Chromatin Immunoprecipitation Sequencing; Histone Modification Analysis

How Are Industry Trends Steering The Expansion Of The NGS Oncology Market?

Major firms in the NGS oncology market are concentrating on the creation of novel solutions such as liquid biopsy research assays, which allow for non-invasive, real-time cancer identification and monitoring by analyzing circulating tumor DNA. A liquid biopsy research assay is a diagnostic procedure that scrutinizes biological fluids, including blood, to identify genetic alterations or other molecular signs of cancer, facilitating non-invasive detection and monitoring of cancer. For example, Illumina Inc., a U.S.-based biotech company noted for its next-generation sequencing (NGS) technology, broadened its oncology product line for NovaSeq X Series users in August 2024. This expansion includes the newly validated high-yield TruSight Oncology 500 (TSO 500 HT) and the revised TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2) liquid biopsy research assay. These upgraded assays allow labs to expand their oncology research capabilities for both tissue and liquid biopsy samples. They feature improved sequencing efficiency, shorter run times, and for the first time, the capacity to process greater sample volumes on the NovaSeq X Series.

Which Organizations Are At The Forefront Of The NGS Oncology Market?

Major companies operating in the NGS oncology market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Eurofins Scientific SE, Illumina Inc., Qiagen N.V., Tecan Trading AG, Myriad Genetics, Takara Bio Inc., Beijing Genomics Institute (BGI), Caris Life Sciences, Foundation Medicine, Paradigm Diagnostics, Pacific Bioscience, Horizon Discovery Group plc , Creative-Biolabs, Xcelris Labs Ltd., Partek Inc., 4baseCare, SciGenom Labs Pvt. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/ngs-oncology-global-market-report

Which Region Holds The Greatest Opportunity For NGS Oncology Market Expansion?

North America was the largest region in the NGS oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the NGS oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24337&type=smp

Browse Through More Reports Similar to the Global NGS Oncology Market 2025, By The Business Research Company

Oncology Information Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-information-systems-global-market-report

Veterinary Oncology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

Hemato Oncology Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemato-oncology-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model